Drug application
MYTREX F (NYSTATIN, TRIAMCINOLONE ACETONIDE)
Drugs@FDA ANDA 062597 · SAVAGE LABS
Key facts
| Drug name | MYTREX F |
|---|---|
| Active ingredients | NYSTATIN, TRIAMCINOLONE ACETONIDE |
| Application type | ANDA |
| Application number | 062597 |
| Company | SAVAGE LABS |
| Dosage forms | CREAM, TOPICAL |
| Strength | 100,000 UNITS/GM;0.1% |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Oct 8, 1985 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.